Cutting Through the Noise: A nuanced discussion on MFN, Rebates, and Premiums | PBM Reform with APCI
Dr. Robert Popovian is a pharmacist, and economist with a deep background in research and public policy. In this episode we have a nuanced discussion on policy impacting pharmacy including PBMs, President Trumps Most Favored Nation Executive Order, Rebates, and insurance premiums.
Links to reso…
Cutting Through the Noise: A nuanced discussion on MFN, Rebates, and Premiums | PBM Reform with APCI
Dr. Robert Popovian is a pharmacist, and economist with a deep background in research and public policy. In this episode we have a nuanced discussion on policy impacting pharmacy including PBMs, President Trumps Most Favored Nation Executive Order, Rebates, and insurance premiums.
Links to reso…
S6, Ep 10- TrumpRx & the Future of Drug Pricing: What Patients Need to Know
In this episode of Healthcare Matters, our hosts unpack the evolving conversation around drug pricing reform—focusing on a new proposal often referred to as “TrumpRx.” Drawing from Robert’s recent co-authored article The Promise of TrumpRx, they explore how direct-to-consumer purchasing, pricing tr…
S7, Ep 1- The $29 Billion Problem: Understanding Influenza's True Economic Toll
In this season premiere of Healthcare Matters, Dr. Robert Popovian and Ben Blanc are joined by Dr. Wayne Winegarden, Senior Fellow and Director of the Center for Medical Economics and Innovation at the Pacific Research Institute, to discuss a new economic study revealing the true cost of influenza …
S7, Ep 2- PBM Reform at an Inflection Point: What Comes Next?
Pharmacy Benefit Manager (PBM) reform has reached a turning point. In this episode of Healthcare Matters, Dr. Robert Popovian and Ben Blanc are joined by Bob Schenk, RPh, to break down the latest wave of federal and state reforms, including the FTC settlement with Express Scripts.
From pharmacy-le…
S7, Ep 3- 340B: Are Patients Seeing the Savings?
In this episode of Healthcare Matters, Dr. Robert Popovian breaks down the 340B drug pricing program through the lens that matters most: what it means for patients. Prompted by Minnesota’s latest transparency report, he explains how a program originally created to support care for uninsured and und…
S7, Ep 4- COVID Antivirals: Are High-Risk Patients Missing the Window?
In this episode of Healthcare Matters, Dr. Robert Popovian is joined by new co-host Angela Degrassi for a conversation about access to oral antiviral treatments for COVID-19, especially for older adults and people living with chronic disease.Prompted by a new CDC report and supported by findings fr…
S7, Ep 5- How ACIP Lawsuits are Impacting Patients: When Vaccine Guidance Becomes an Access Problem
In this episode of Healthcare Matters, Dr. Robert Popovian and co-host Angela Degrassi discuss why uncertainty surrounding the CDC’s Advisory Committee on Immunization Practices, known as ACIP, matters far beyond Washington, DC.
The conversation explains how ACIP recommendations are connected to t…
S7, Ep 6- 340B Program & Hospital Charity Care: What Patients Need to Know
In this episode of Healthcare Matters, Dr. Robert Popovian and co-host Angela Degrassi discuss the 340B Drug Discount Program and why a program created to help vulnerable patients has become an important issue for patient access, hospital transparency, and accountability.
The conversation explain…
S7, Ep 7- The Inflation Reduction Act: Are Lower Medicare Drug Prices Reaching Patients?
In this episode of Healthcare Matters, Dr. Robert Popovian and co-host Angela Degrassi examine the Inflation Reduction Act’s Medicare Drug Price Negotiation Program and whether lower prices negotiated by the government are translating into meaningful savings for patients at the pharmacy counter.
T…
ポッドキャスト検索エンジン
当社の Web サイトを使用して、人、場所、トピックごとに 3,828,953 ポッドキャストや 196,524,886 エピソードを検索できます。
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
